Indian Government Says The Popular Pain Killer Meftal Spas May Not Be A Good Choice
Meftal-Spas is a commonly used anti-inflammatory drug (NSAID) that are used to get rid of pain. The tablet is widely used by women especially who are under their period. The Indian Pharmacopoeia Commission (IPC) has issued a drug safety alert about this commonly used painkiller claiming it to trigger severe allergic reactions like the DRESS (Drug Rash Eosinophilia and Systemic Symptoms) syndrome that effects the internal organs.
The alert from IPC read, “Helathcare professionals, patients and consumers are advised to closely monitor the possibility of the above adverse drug reactions (ADR) associated with the” said drug.
Doctors opined that the reactions are extremely rare and already known so they asses the patients while scribbling out the drug in limited dosage. The doctors also opined that the reaction may depend on individual patient, they had not observed any ADR during their practice.
The mefenamic acid is a prescription medication. But the drug is widely used in India for several purposes like relieving menstrual pain, muscles and joint pain, head ache and even for fighting high fever in children. Mefenamic acid is sold in the form of Meftal, Mefkind, Mefanorma and Ibuclin P. The drug shows similarities with Aspirin and ibuprofen.
THE DRESS Syndrome can be identified as the severe allergic reactions that caused by certain medications. The allergies can be potentially deadly and can be seen in around total of 10 percent of individuals. The Syndrome can be characterized by high fever haematological abnormalities, skin rashes and internal organ involvements.
Another concern that comes with the use of mefenamic acid is the gastrointestinal issues. Dr. Gautham Bhansali of Bombay Hospital said, “prolonged use of drugs like Meftal may increase the risk of stomach ulcers, bleeding and complications”.
Some experts also opined that the drug may have renal (Kidney ) complications as the potential side effect. Meftal, which belong to NSAID category may have increased risk of cardiovascular issues especially for individuals who have pre-existing heart issues.
With inputs from agencies.
